Myasthenia gravis represents chronic autoimmune disease that primarily affects the neuromuscular junction. This junction facilitates the conveyance of signals from nerves to muscles, enabling movement. In myasthenia gravis, the body's immune system mistakenly attacks these receptors, causing weakness and fatigue in the motor units. The indications